Nilabh Shastri - Towards understanding classical and non-classical MHC-I antigen processing and presentation

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Major histocompatibility complex class I (MHC-I) peptide antigen processing and presentation are crucial for immune surveillance.
• Recent advances in immuno-oncology, pathogen mutation studies, and vaccine design have renewed interest in MHC-I pathways.
• Understanding antigen processing is key to developing effective immunotherapies and vaccines.

Purpose of the Study:

• To investigate the characterization of cryptic MHC-I peptide antigen epitopes.
• To elucidate the role of the aminopeptidase ERAAP (ERAP1/2 / ARTS1/LRAP) in N-terminal trimming of peptide antigen precursors.
• To explore the implications of these findings for novel therapeutic approaches in immunotherapy and vaccine design.

Main Methods:

• Characterization of MHC-I peptide antigen epitopes.
• Analysis of N-terminal trimming by ERAAP in the endoplasmic reticulum (ER).
• Investigating the impact on MHC-I complex assembly and cell surface presentation.

Main Results:

• Identification of cryptic MHC-I peptide antigen epitopes originating from untranslated regions.
• Demonstration of N-terminal trimming of peptide antigen precursors by ERAAP in the ER.
• These processes occur prior to MHC-I complex assembly and cell surface exposure.

Conclusions:

• The study sheds light on previously uncharacterized aspects of MHC-I antigen processing.
• Findings have significant implications for the development of novel immunotherapies.
• The research contributes to advancements in modern vaccine design strategies.